ArticleFrontiers in pharmacology2018
A Review of the Phytochemistry and Pharmacology of
Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 121 citations in OpenAlex.
- Appraising the therapeutical potentials ofFrontiers in pharmacology · 2022Pooled it
- Therapeutic Effects ofPediatric discovery · 2025Article
- Therapeutic potential ofRSC advances · 2025Review
- Phyllanthin from Phyllanthus amarus exerts neuroprotective effects against spinal cord injury in experimental rats.Arquivos de neuro-psiquiatria · 2025Article
- Unraveling the treasure trove of phytochemicals in mitigating the Salmonella enterica infection.Folia microbiologica · 2025Review
- Meniran (RSC advances · 2025Article
- Chinese herbal medicines: the modifier of hepatocellular carcinoma targeting Wnt/β-catenin signaling pathway.Frontiers in pharmacology · 2025Review
- The Meaning of Plants' Names: A New Discovering Approach to Its Medicinal and/or Toxic Properties.Evidence-based complementary and alternative medicine : eCAM · 2024Article
- A review ofFrontiers in pharmacology · 2024Review
- Evaluation of Salicylic Acid and Methyl Jasmonate as Elicitors inMolecules (Basel, Switzerland) · 2023Article
- Nutritional Value, Volatile Components, Functional Metabolites, and Antibacterial and Cytotoxic Activities of Different Parts ofPlants (Basel, Switzerland) · 2023Article
- Traditional medical practices for children in five islands from the Society archipelago (French Polynesia).Journal of ethnobiology and ethnomedicine · 2023Review
- Article
- Diversity of Fungal Communities on Diseased and Healthy Cinnamomum burmannii Fruits and Antibacterial Activity of Secondary Metabolites.Microbiology spectrum · 2023Article
- Genome ofFrontiers in plant science · 2023Article
- Article
- The activity of Meniran (Veterinary world · 2022Article
- Application of chloroplast genome in the identification ofFrontiers in plant science · 2022Article
- Methyl Brevifolincarboxylate Attenuates Free Fatty Acid-Induced Lipid Metabolism and Inflammation in Hepatocytes through AMPK/NF-κB Signaling Pathway.International journal of molecular sciences · 2021Article
- LC-ESI-QTOF-MS/MS Analysis, Cytotoxic, Antiviral, Antioxidant, and Enzyme Inhibitory Properties of Four Extracts ofInternational journal of molecular sciences · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The genus
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.